XML 35 R4.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated and Combined Statements of Earnings (FY) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 28, 2024
Jun. 30, 2023
Jun. 28, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]              
Sales $ 1,288 $ 1,253 $ 2,534 $ 2,478 $ 5,021 $ 4,870 $ 4,700
Cost of sales (514) (529) (1,013) (1,046) (2,120) (2,110) (1,987)
Gross profit 774 724 1,521 1,432 2,901 2,760 2,713
Operating costs:              
Selling, general and administrative expenses (414) (378) (808) (738) (1,536) (1,431) (1,428)
Research and development expenses (61) (57) (121) (113) (225) (217) (244)
Operating profit 299 289 592 581 1,140 1,112 1,041
Nonoperating income (expense):              
Other income (expense), net 1 (14) (14) (14) (14) 1 6
Interest expense, net (30) 0 (58) 0 (30) 0 0
Earnings before income taxes 270 275 520 567 1,096 1,113 1,047
Income taxes (67) (66) (133) (133) (257) (268) (186)
Net earnings $ 203 $ 209 $ 387 $ 434 $ 839 $ 845 $ 861
Net earnings per common share:              
Basic (in usd per share) $ 0.82 $ 0.85 $ 1.57 $ 1.76 $ 3.41 $ 3.43 $ 3.5
Diluted (in usd per share) $ 0.81 $ 0.85 $ 1.55 $ 1.76 $ 3.4 $ 3.43 $ 3.5
Average common stock and common equivalent shares outstanding:              
Basic (in shares) 247.2 246.3 247.1 246.3 246.4 246.3 246.3
Diluted (in shares) 249.3 246.3 249.1 246.3 246.8 246.3 246.3